Unnatural Products Signs ~$1.8B Licensing Deal with Novartis to Develop Macrocyclic Peptide Therapeutics
Shots: Ref: Globenewswire | Image: UNP & Novartis | Press Release Related News: Unnatural Products Collaborates with…
Read article →
Transforming Lupus Management: Caterina Brindicci Shares AstraZeneca’s Approach to Patient-Focused Care
Shots: Saurabh: Congratulations on the publication of the TULIP-SC full results! Could you share your high-level…
Read article →
Novo Nordisk Reports EC Approval of Higher Injectable Wegovy Dose for Weight Management
Shots: Ref: Novo Nordisk | Image: Novo Nordisk | Press Release Related News: Novo Nordisk Reports P-III (REIMAGINE 2)…
Read article →
Accord BioPharma’s Filkri (Biosimilar, Neupogen) Receives the US FDA Approval
Shots: Ref: PRnewswire | Image: Accord | Press Release Related News: Accord BioPharma Receives the US FDA’s Approval for…
Read article →
Novartis Reports Topline P-III (RemIND) Trial Results on Remibrutinib in Chronic Inducible Urticaria (CIndU)
Shots: Ref: Novartis | Image: Novartis | Press Release Related News: Novartis Reports Final P-III (ALIGN) Trial Data…
Read article →
Pfizer Reports P-III (BREAKWATER) Trial Cohort 3 Results on Braftovi (Encorafenib) Regimen for Certain Metastatic Colorectal Cancer (mCRC)
Shots: Ref: Pfizer | Image: Pfizer | Press Release Related News: Pfizer Receives the US FDA Priority Review for Hympavzi…
Read article →
BMS Reports the US FDA’s NDA Acceptance for Iberdomide Combination in R/R Multiple Myeloma
Shots: Ref: BMS | Image: BMS | Press Release Related News: Janux Therapeutics and BMS Forge ~$850M Deal to Develop…
Read article →
Cytokinetics Reports the EC Approval of Myqorzo (Aficamten) for Obstructive Hypertrophic Cardiomyopathy (oHCM)
Shots: Ref: Cytokinetics | Image: Cytokinetics | Press Release Related News: Cytokinetics Launches Myqorzo in the US for…
Read article →